Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hydrocarbon/krabbamein

Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 144 niðurstöður

Tumor cell growth-inhibiting pharmaceutical compositions containing phosphino-hydrocarbon-gold, silver or copper complexes

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
BACKGROUND OF THE INVENTION This invention relates to novel bis[bis (diphenylphosphino)hydrocarbon]-, bis[bis(diethylphosphino)hydrocarbon]-, bis[diphenylphosphino-diethylphosphino)hydrocarbon]gold(I), silver(I) or copper(I) complexes or tris[bis(diphenylphosphino)ethane]dicopper (I) derivatives
BACKGROUND OF THE INVENTION This invention relates to novel .alpha.,.omega.-bis(disubstitutedphosphino)hydrocarbon compounds, digold(I), digold(III), disilver(I) or dicopper(I) complexes thereof, pharmaceutical compositions containing, as an active ingredient,

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 2, 2016 is named 701586-067982-US_SL.txt and is 8,192 bytes in size. FIELD OF THE

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 20, 2013 is named 701586-067982-US_SL.txt and is 8,192 bytes in size. FIELD OF THE

Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
SEQUENCE LISTING The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Feb. 20, 2013 is named 701586-067982-US_SL.txt and is 8,192 bytes in size. FIELD OF THE

Compounds for treatment of cancer

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention relates to novel compounds having anti-cancer activity, methods of making these compounds, and their use for treating various forms of cancer. BACKGROUND OF THE INVENTION Cancer is the second most common cause of death in the United States, exceeded only

Methods for preventing and treating cancer using N-thiolated .beta.-lactam compounds and analogs thereof

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention relates to N-thiolated .beta.-lactam compounds, and analogs and derivatives thereof, which potently induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation. Specifically, the invention relates to methods of treating conditions

Methods for preventing and treating cancer using N-thiolated .beta.-lactam compounds and analogs thereof

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention relates to N-thiolated .beta.-lactam compounds, and analogs and derivatives thereof, which potently induce neoplastic cell apoptosis or inhibit neoplastic cell proliferation. Specifically, the invention relates to methods of treating conditions
BACKGROUND OF THE INVENTION This invention relates to novel [bis(diphenylphosphino)alkyl]bis-gold[I] derivatives which have tumor cell growth-inhibiting activity, pharmaceutical compositions containing such novel derivatives, and a method for treating tumor cells sensitive to such derivatives by

Synthetic C-glycolipid and its use for treating cancer, infectious diseases, and autoimmune diseases

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The invention is directed to novel synthetic C-glycolipids, which are useful in treating cancer, infectious diseases and autoimmune diseases. Specifically, the invention is directed to novel synthetic analogs of .alpha.-C-galactosylceramides, which are potent mediators of

Synthetic C-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The invention is directed to novel synthetic C-glycolipids, which are useful in treating cancer, infectious diseases and autoimmune diseases. Specifically, the invention is directed to novel synthetic analogs of .alpha.-C-galactosylceramides, which are potent mediators of

Antigenic conjugates of polycyclic aromatic hydrocarbons to nucleosides

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention relates to novel immunologic reagents and their use in assays for the detection of polycyclic aromatic hydrocarbon (PAH)-DNA adducts as well as heteropolycyclic aromatic hydrocarbon (HAH)-DNA adducts. These adducts are uniquely important biomarkers for

Near-infrared super-continuum lasers for early detection of breast and other cancers

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
This application is related to U.S. provisional application Ser. No. 61/747,477 filed Dec. 31, 2012; Ser. No. 61/747,481 filed Dec. 31, 2012; Ser. No. 61/747,485 filed Dec. 31, 2012; Ser. No. 61/747,487 filed Dec. 31, 2012; Ser. No. 61/747,492 filed Dec. 31, 2012; Ser. No. 61/747,472 filed Dec. 31,

5'-deoxy-cytidine derivative administration to treat solid tumors

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
FIELD OF THE INVENTION The present invention is concerned with novel 5'-deoxy-cytidine derivatives, pharmaceutical compositions, a kit thereof for assisting a delivery of 5-fluorouracil selectively to tumor tissues and process for manufacturing the novel 5'-deoxy-cytidine

Pharmaceutical composition for inhibiting the growth of viruses and cancers

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
TECHNICAL FIELD This invention is a method of treating cancer, both carcinomas and sarcomas, and viral infections, in particular HIV through the administration of a pharmaceutical composition containing a benzimidazole derivative. The composition is also claimed. BACKGROUND OF THE INVENTION Cancers
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge